These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1575775)

  • 1. Effects of nonenzymatic glycosylation and fatty acids on tryptophan binding to human serum albumin.
    Bohney JP; Feldhoff RC
    Biochem Pharmacol; 1992 Apr; 43(8):1829-34. PubMed ID: 1575775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromatographic analysis of the effects of fatty acids and glycation on binding by probes for Sudlow sites I and II to human serum albumin.
    Anguizola J; Debolt E; Suresh D; Hage DS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 May; 1021():175-181. PubMed ID: 26468085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Location of the medium chain fatty acid site on human serum albumin. Residues involved and relationship to the indole site.
    Lee IY; McMenamy RH
    J Biol Chem; 1980 Jul; 255(13):6121-7. PubMed ID: 7391008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorometric and mass spectrometric analysis of nonenzymatic glycosylated albumin.
    Zoellner H; Hou JY; Hochgrebe T; Poljak A; Duncan MW; Golding J; Henderson T; Lynch G
    Biochem Biophys Res Commun; 2001 Jun; 284(1):83-9. PubMed ID: 11374874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nonenzymatic glycosylation on the magnetic resonance imaging (MRI) contrast agent binding to human serum albumin.
    Henoumont C; Laurent S; Muller RN; Vander Elst L
    J Med Chem; 2012 Apr; 55(8):4015-9. PubMed ID: 22420713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectroscopic studies of the effects of glycation of human serum albumin on L-Trp binding.
    Barzegar A; Moosavi-Movahedi AA; Sattarahmady N; Hosseinpour-Faizi MA; Aminbakhsh M; Ahmad F; Saboury AA; Ganjali MR; Norouzi P
    Protein Pept Lett; 2007; 14(1):13-8. PubMed ID: 17266645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long chain fatty acids alter the interactive binding of ligands to the two principal drug binding sites of human serum albumin.
    Yamasaki K; Hyodo S; Taguchi K; Nishi K; Yamaotsu N; Hirono S; Chuang VTG; Seo H; Maruyama T; Otagiri M
    PLoS One; 2017; 12(6):e0180404. PubMed ID: 28662200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-enzymatic glycation of human albumin does not alter its palmitate binding.
    Murtiashaw MH; Winterhalter KH
    Diabetologia; 1986 Jun; 29(6):366-70. PubMed ID: 3743922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular dynamics study of conformational changes in human serum albumin by binding of fatty acids.
    Fujiwara S; Amisaki T
    Proteins; 2006 Aug; 64(3):730-9. PubMed ID: 16783783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of bilirubin and long-chain fatty acids to human serum albumin with general remarks on displacement of firmly bound ligands.
    Brodersen R; Funding L
    Scand J Clin Lab Invest; 1977 May; 37(3):257-66. PubMed ID: 616051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The binding of L-tryptophan to serum albumins in the presence of non-esterified fatty acids.
    Cunningham VJ; Hay L; Stoner HB
    Biochem J; 1975 Mar; 146(3):653-8. PubMed ID: 1147909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locating high-affinity fatty acid-binding sites on albumin by x-ray crystallography and NMR spectroscopy.
    Simard JR; Zunszain PA; Ha CE; Yang JS; Bhagavan NV; Petitpas I; Curry S; Hamilton JA
    Proc Natl Acad Sci U S A; 2005 Dec; 102(50):17958-63. PubMed ID: 16330771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis.
    Simard JR; Zunszain PA; Hamilton JA; Curry S
    J Mol Biol; 2006 Aug; 361(2):336-51. PubMed ID: 16844140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromatographic studies of changes in binding of sulfonylurea drugs to human serum albumin due to glycation and fatty acids.
    Basiaga SB; Hage DS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Nov; 878(30):3193-7. PubMed ID: 20974553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal serum protein binding of acidic drugs in diabetes mellitus.
    Ruiz-Cabello F; Erill S
    Clin Pharmacol Ther; 1984 Nov; 36(5):691-5. PubMed ID: 6488690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonenzymatic glycosylation of human serum albumin alters its conformation and function.
    Shaklai N; Garlick RL; Bunn HF
    J Biol Chem; 1984 Mar; 259(6):3812-7. PubMed ID: 6706980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of dietary habits and pathological conditions on the binding of theophylline to serum albumin.
    Bojko B; Sułkowska A; Maciazek-Jurczyk M; Równicka J; Sułkowski WW
    J Pharm Biomed Anal; 2010 Jul; 52(3):384-90. PubMed ID: 19800191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of aliphatic fatty acids on the binding of Phenol Red to human serum albumin.
    Kragh-Hansen U
    Biochem J; 1981 Jun; 195(3):603-13. PubMed ID: 7316975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of fatty acid binding ability of glycated human serum albumin.
    Yamazaki E; Inagaki M; Kurita O; Inoue T
    J Biosci; 2005 Sep; 30(4):475-81. PubMed ID: 16184009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fatty acid analogue 11-(dansylamino)undecanoic acid is a fluorescent probe for the bilirubin-binding sites of albumin and not for the high-affinity fatty acid-binding sites.
    Wilton DC
    Biochem J; 1990 Aug; 270(1):163-6. PubMed ID: 2396975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.